Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group
Academic Article
Publication Date:
2021
Iris type:
1.1 Articolo in rivista
Keywords:
COVID-19; Europe; Humans; Immunotherapy, Adoptive; Leukemia, B-Cell; Lymphoma, B-Cell; Prognosis; Treatment Outcome
List of contributors:
Spanjaart, A. M.; Ljungman, P.; de La Camara, R.; Tridello, G.; Ortiz-Maldonado, V.; Urbano-Ispizua, A.; Barba, P.; Kwon, M.; Caballero, D.; Sesques, P.; Bachy, E.; Di Blasi, R.; Thieblemont, C.; Calkoen, F.; Mutsaers, P.; Maertens, J.; Giannoni, L.; Nicholson, E.; Collin, M.; Vaz, C. P.; Metafuni, E.; Martinez-Lopez, J.; Dignan, F. L.; Ribera, J. -M.; Nagler, A.; Folber, F.; Sanderson, R.; Bloor, A.; Ciceri, F.; Knelange, N.; Ayuk, F.; Kroger, N.; Kersten, M. J.; Mielke, S.
Published in: